Terminated OBSERVATIONAL NCT01201928

Pulmonary Function Substudy for Subjects Enrolled in Studies MKC-TI-161, MKC-TI-162 or MKC-TI-166

A Phase 3b, Multicenter, Clinical Trial to Evaluate Pulmonary Function in a Subset of Subjects With Type 1 or Type 2 Diabetes

Sponsor: Mannkind Corporation

Conditions Type 1 Diabetes Mellitus Type 2 Diabetes Mellitus

Interventions Comparator administered in parent trial Technosphere Insulin Inhalation Powder

Updated 8 times since 2017 Last updated: Dec 5, 2012 Started: Oct 31, 2010 Primary completion: Mar 31, 2011 Completion: Mar 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Parent trials were either not initiated or terminated

Other terminated trials from Mannkind Corporation

More terminations from Mannkind Corporation

Other Type 1 Diabetes Mellitus trials with similar outcome

Browse all Type 1 Diabetes Mellitus trials

Listed as NCT01201928, this observational or N/A phase trial focuses on Type 1 Diabetes Mellitus and Type 2 Diabetes Mellitus and remains terminated or withdrawn. Sponsored by Mannkind Corporation, it has been updated 8 times since 2010, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

8 versions recorded

Sep 2025 — Present [monthly]

Terminated
Sep 2024 — Sep 2025 [monthly]

Terminated
Jul 2024 — Sep 2024 [monthly]

Terminated
Jan 2021 — Jul 2024 [monthly]

Terminated
Jun 2018 — Jan 2021 [monthly]

Terminated

▶ Show 3 earlier versions

Apr 2018 — Jun 2018 [monthly]

Terminated

Phase: PHASE3 → None
Feb 2017 — Apr 2018 [monthly]

Terminated PHASE3
Jan 2017 — Feb 2017 [monthly]

Terminated PHASE3

First recorded

Oct 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Mannkind Corporation

Data source: Mannkind Corporation

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Arlington, United States , Atlanta, United States , Billings, United States , Dallas, United States , Dunwoody, United States , Fresno, United States , Greenville, United States , Long Beach, United States , Michigan City, United States , Mineola, United States and 3 more locations